Selection of a palatable dietary option is not preferentially reduced by cannabinoid CB1 receptor antagonist AM251 in female C57Bl/6J mice

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 1, 2009, Pages 119-123

  Mathes, Clare M ^a   Ferrara, Marco ^a   Rowland, Neil E ^a  

^a University of Florida ^*  (United States)

Author keywords

Body weight; Choice; Diet induced obesity; Feeding; Overconsumption

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE;

ANIMAL EXPERIMENT; ARTICLE; C57BL 6 MOUSE; CALORIC INTAKE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; FEEDING BEHAVIOR; FEMALE; FOOD PREFERENCE; MOUSE; NONHUMAN; OBESITY; PALATABILITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; CHOICE BEHAVIOR; DIET; DIETARY FATS; DIETARY SUCROSE; ENERGY INTAKE; FEMALE; FOOD PREFERENCES; MICE; MICE, INBRED C57BL; NUTRITIVE VALUE; OBESITY; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; TIME FACTORS;

MUS; RATTUS;

EID: 70349192691     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.07.016     Document Type: Article

References (38)

1. Arnone M., Maruani J., Chaperon F., Thiebot M., Poncelet M., Soubrie P., et al. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 132 (1997) 104-106
2. Avena N.M., Rada P., and Hoebel B.G. Evidence for sugar addiction: behavioral and neurochemical effects of intermittent, excessive sugar intake. Neurosci Biobehav Rev 32 1 (2008) 20-39
3. Bi S., Chen J., Behles R.R., Hyun J., Kopin A.S., and Moran T.H. Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors. Am J Physiol Regul Integr Comp Physiol 293 1 (2007) R55-63
4. Bray G.A., and Champagne C.M. Beyond energy balance: there is more to obesity than kilocalories. J Am Diet Assoc 105 5 Suppl 1 (2003) S17-23
5. Collins S., Martin T.L., Surwit R.S., and Robidoux. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 81 (2004) 243-248
6. Colombo G., Agabio R., Diaz G., Lobina C., Reali R., and Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63 8 (1998) PL113-PL117
7. Cottone P., Sabino V., Steardo L., and Zorrilla E.P. Intermittent preferred food access reduces the reinforcing efficacy of chow in rats. Am J Physiol Regul Integr Comp Physiol 295 4 (2008) R1066-R1076
8. Crews E.C., and Rowland N.E. Role of angiotensin in body fluid homeostasis of mice: effect of losartan on water and NaCl intakes. Am J Physiol Regul Integr Comp Physiol 288 3 (2005) R638-R644
9. Drenowski A., and Levine A.S. Sugar and fat - from genes to culture. J Nutr 133 3 (2003) 829S-830S
10. Escarten-Perez R.E., Cendejas-Trejo N.M., Cruz-Martinez A.M., Gonzalez-Hernandez B., Mancilla-Diaz J.M., and Floran-Garuno B. Role of cannabinoid CB1 receptors on macronutrient selection and satiety in rats. Physiol Behav 96 4-5 (2009) 246-250
11. Foltin R.W., and Haney M. Effects of the cannabinoid antagonist SR141716 (Rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates. Pharmacol Biochem Behav 86 4 (2007) 766-773
12. Freedland C.S., Poston J.S., and Porrino L.J. Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav 67 2 (2000) 265-270
13. Gatley S.J., Gifford A.N., Volkow N.D., Lan R., and Makriyannis A. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol 307 (1996) 331-338
14. Gessa C.L., Orru A., Lai P., Maccioni P., Lecca R., Lobina C., et al. Lack of tolerance to the suppressing effect of rimonabant on chocolate intake in rats. Psychopharmacology (Berl) 185 2 (2006) 248-254
15. Higgs S., Williams C.M., and Kirkham T.C. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 165 4 (2003) 370-377
16. Hildebrandt A.L., Kelly-Sulivan D.M., and Black S.C. Antiobesity effects of chronic CB1 receptor antagonist treatment in diet-induced obese mice. Eur J Pharmacol 462 (2005) 125-132
17. 9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test. Physiol Behav 90 (2007) 425-430
18. Koch J.E. Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. Pharmacol Biochem Behav 68 3 (2003) 539-543
19. Levin B.E. Factors promoting and ameliorating the development of obesity. Physiol Behav 86 5 (2005) 633-639
20. Mathes CM. Murine models of overconsumption and binge-eating: Effect of melanocortin-4 and cannabinoid CB1 receptor activity on caloric intake and body weight in female C57Bl/6J mice. Dissertation presented to the Graduate School of the University of Florida, copyright 2008.
21. Mathes C.M., Ferrara M., Suresh D., Andreasej A., Haskell-Luevano C., and Rowland N.E. Effect of level of dysfunction of the melanocortin-4 receptor (MC4R) on overconsumption and binge-like eating of a palatable dessert in mice. Appetite 49 1 (2007) 312
22. Mathes C.M., Ferrara M., and Rowland N.E. Cannabinoid CB1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats. Am J Physiol Regul Integr Comp Physiol 295 1 (2008) R67-75
23. Matyskova R., Maletinska L., Maixnerova J., Pirnik Z., Kiss A., and Zelezna B. Comparison of the obesity phenotypes related to monosodium glutamate effect on arcuate nucleus and/or the high fat diet feeding in C57Bl/6 and NMRI mice. Physiol Res 57 5 (2007) 727-737
24. McLaughlin P.J., Winston K., Swezey L., Wisniecki A., Aberman J., Tardif D.J., et al. The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol 14 (2003) 583-588
25. Miller C.C., Murray T.F., Freeman K.G., and Edwards G.L. Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain. Physiol Behav 80 5 (2004) 611-616
26. Rasmussen E.B., and Huskinson S.L. Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats. Behav Pharmacol 19 7 (2008) 735-742
27. Ravinet-Trillou C., Delgorge C., Menet C., Arnone M., and Soubrie P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity, and enhanced insulin sensitivity. Int J Obes Realt Metab Disord 28 (2004) 640-648
28. Ravussin E., and Bogardus C. Energy balance and weight regulation: genetics versus environment. Br J Nutr 83 Suppl 1 (2000) S17-S20
29. Rowland N.E., Mukherjee M., and Robertson K. Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats. Psychopharmacology 159 1 (2001) 111-116
30. Sclafani A., and Springer D. Dietary obesity in adult rats: similarities to hypothalamic and human obesity syndromes. Physiol Behav 17 3 (1976) 461-471
31. Sclafani A., and Glendining J.I. Sugar and fat conditioned flavor preferences in C57BL/6J and 129 mice: oral and postoral interactions. Am J Physiol Regul Integr Comp Physiol 289 3 (2005) R712-R720
32. Simiand J., Keane M., Keane P.E., and Soubrie P. SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9 2 (1998) 179-181
33. Sink K.S., Vemuri V.K., Olszewska T., Makriyannis A., and Salamone J.D. Cannabinoid CB1 antagonists and dopamine antagonists produce different results on a task involving response allocation and effort-related choice in food seeking behavior. Psychopharmacology (Berl.) 196 4 (2008) 565-574
34. South T., Deng C., and Huang X.F. AM 251 and beta-Funaltrexamine reduce fat intake in a fat-preferring strain of mouse. Behav Brain Res 181 1 (2007) 153-157
35. Stein C.J., and Colditz G.A. The epidemic of obesity. J Clin Endocrinol Metab 89 (2004) 2522-2525
36. Verty A.N., McGregor I.S., and Mallet P.E. Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett 354 3 (2004) 217-220
37. Vrang N., Madsen A.N., Tang-Christensen M., Hansen G., and Larsen P.J. PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 291 2 (2006) R367-R375
38. Ward S.J., and Dykstra L.A. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940). Behav Pharmacol 16 5-6 (2005) 381-388